Who Paid My Doc
Inderjit Anand
Cardiovascular Disease Minneapolis, MN Medical Doctor
NPI 1871514513 CMS profile 473581
1 Veterans Dr # 111C, Minneapolis, MN 55417
General payments
$384,346
Research payments
$47,984
Ownership & investment interest
$0
Through program year 2025, Inderjit Anand of Minneapolis, MN is reported in the CMS Open Payments database as having received $384,346 across 128 general payments and $47,984 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 99th percentile of Cardiovascular Disease profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | Research | $46,400 | 16 | |
| 2023 | General | $13,512 | 8 | |
| 2022 | General | $595 | 2 | |
| 2021 | General | $55,420 | 14 | |
| 2021 | Research | $1,584 | 1 | |
| 2020 | General | $218,428 | 63 | |
| 2019 | General | $96,391 | 41 |
Beside peers
- Inderjit Anand
- Cardiovascular Disease median
- Middle half of Cardiovascular Disease
- National median
In program year 2025, general payments to Inderjit Anand were reported at $0. Among 16,617 Cardiovascular Disease profiles paid that year, the median was $432 and the middle half received between $132 and $1,252.
Show as a table
| Year | Inderjit Anand | Cardiovascular Disease median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $96,391 | $450 | $127–$1,392 | $163 |
| 2020 | $218,428 | $242 | $77–$751 | $114 |
| 2021 | $55,420 | $335 | $101–$1,037 | $132 |
| 2022 | $595 | $395 | $121–$1,211 | $149 |
| 2023 | $13,512 | $443 | $136–$1,283 | $160 |
| 2024 | $0 | $450 | $136–$1,323 | $164 |
| 2025 | $0 | $432 | $132–$1,252 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
145 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Cardiovascular Disease in Minnesota
Jeffrey Chambers
Cardiovascular Disease · Minneapolis, MN
Srijoy Mahapatra
Cardiovascular Disease · Rochester, MN
Markus Meyer
Cardiovascular Disease · Minneapolis, MN
Robert Schwartz
Cardiovascular Disease · Minneapolis, MN
Robert Vantassel
Cardiovascular Disease · Minneapolis, MN
Charanjit Rihal
Cardiovascular Disease · Rochester, MN
Related records
Cardiovascular Disease in Minnesota
Practitioners in the same specialty and state, ranked by reported value.
All Cardiovascular Disease
Everyone recorded under this specialty, nationwide.
Doctors in Minnesota
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.